Cao et al. later confirmed that gemcitabine disrupts WTAP protein expression in pancreatic cancer, resulting in decreased m6A modification of MYC, reduced RNA stability, and impeded cancer progression [36]. Here, MYC is linked to familial pancreatic carcinoma.